Our discovery warrants further investigation, which may ultimately define ZNF469 as an ACMG pathogenic gene in aneurysmal diseases, which would alter the standard of care for screening and the management of patients who have strong personal and family histories of aortic and arterial aneurysmal diseases. Here, ZNF469 is linked to Vascular dilatation.